Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
Study NCT ID:
NCT04752566
Status:
COMPLETED
Last Update Posted:
2025-09-08
First Post:
2021-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-09
First Submit QC Date:
None
Study First Post Date:
2021-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-06
Results First Submit QC Date:
None
Results First Post Date:
2024-02-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-04
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED